Search 7,500+ licensed pharmacies to find the best value, closest location, and fastest turnaround for
.
AOD-9604 is a synthetic peptide analog of the C-terminal fragment of human growth hormone (hGH176-191). It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat storage) by activating fat cell beta-3 receptors — without the insulin-like or growth-promoting effects of full HGH.
AOD-9604 has no FDA-approved commercial equivalent. Compounding pharmacies are the only legal source for AOD-9604 preparations for human use.
Compare up to 7,500 pharmacies across the USA.
AOD-9604 (Anti-Obesity Drug 9604) was originally developed by Metabolic Pharmaceuticals as an obesity treatment based on the fat-mobilizing activity of hGH's C-terminal region. It demonstrated significant fat loss in clinical trials with no effect on blood glucose or IGF-1 — the two major limitations of HGH therapy.
AOD-9604 is now used in weight management and body composition protocols, often alongside GLP-1 agonists, sermorelin, or ipamorelin/CJC-1295 for comprehensive metabolic optimization.
Visceral fat reduction, body composition optimization, metabolic syndrome, obesity adjunct therapy, combined with GLP-1 or GH peptide protocols
SubQ injection: 300mcg daily in the morning on an empty stomach
Allow 30 minutes before eating for maximum effect
Very well tolerated. Mild injection site reactions, occasional headache. No significant effects on blood glucose, IGF-1, or thyroid function — key advantage over full HGH.
Submit a quote request to find the lowest price. Quotes delivered to your inbox.
Find Lowest Price.png){kind=spacer}
